Perfuse Therapeutics, Inc. — Form D
Perfuse Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-04-04. The offering totals $4.0M, of which $2.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2019-04-04
- Form: D
- Accession: 0001771941-19-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $2.0M
- Remaining: $2.0M
- Investors: 6
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-336458
Issuer
- Name: Perfuse Therapeutics, Inc.
- CIK: 0001771941
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 1700 OWENS STREET SUITE 540, SAN FRANCISCO, CA, 94158
- Phone: 1-415-272-1083
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Sevgi Gurkan | Related Person | San Francisco, CA |
| Chau Khuong | Related Person | San Francisco, CA |
| Christy Shaffer | Related Person | Durham, NC |
| Christy Shaffer | Director | Durham, NC |
| Chau Khuong | Director | San Francisco, CA |
| Hongbo Lu | Director | San Diego, CA |
| Sevgi Gurkan | Director | San Francisco, CA |
| Sevgi Gurkan | Executive Officer | San Francisco, CA |
| Sevgi Gurkan | Promoter | San Francisco, CA |
| Dan Becker | Director | San Francisco, CA |
| Jerry Cagle | Director | San Francisco, CA |
Other filings by this issuer (1)
More